Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 25/01/30

Trade details

Type: Insider sale
Amount: $50,654.17
Shares · price: 2,557 sh · $19.81 a share
Held after: 39,803 sh
Stock: Nurix Therapeutics NRIX
Person: Hans van HouteCFO
Trade date: 25/01/30
Filed: 25/01/30
Days to filing: 0 days

Sold 6.0% of holdings

Share of holding sold: 6.0%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/31~25/03/01

Hans van Houte's recent trades

Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$110.6K
4,761 sh
$110.6K
Filed 08/04
Traded 08/04
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$223.4K
13,473 sh
$223.4K
Filed 05/05
Traded 05/05
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$9,999
582 sh
$9,999
Filed 05/05
Traded 05/05
Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$238K
14,055 sh
$238K
Filed 05/05
Traded 05/05
Hans van HouteCFO
SellNurix Therapeutics
Sell
Nurix Therapeutics
NRIX
$39.8K
2,388 sh
$39.8K
Filed 04/30
Traded 04/30